CGEM
Price
$8.06
Change
+$0.32 (+4.13%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
457.24M
22 days until earnings call
Intraday Buy/Sell Signals
NRIX
Price
$9.18
Change
-$0.54 (-5.56%)
Updated
Oct 14 closing price
Capitalization
705.41M
126 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

CGEM vs NRIX

Header iconCGEM vs NRIX Comparison
Open Charts CGEM vs NRIXBanner chart's image
Cullinan Therapeutics
Price$8.06
Change+$0.32 (+4.13%)
Volume$3.95K
Capitalization457.24M
Nurix Therapeutics
Price$9.18
Change-$0.54 (-5.56%)
Volume$1.27M
Capitalization705.41M
CGEM vs NRIX Comparison Chart in %
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. NRIX commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (CGEM: $7.74 vs. NRIX: $9.18)
Brand notoriety: CGEM and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 181% vs. NRIX: 125%
Market capitalization -- CGEM: $457.24M vs. NRIX: $705.41M
CGEM [@Biotechnology] is valued at $457.24M. NRIX’s [@Biotechnology] market capitalization is $705.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CGEM and NRIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 5 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • CGEM’s TA Score: 5 bullish, 3 bearish.
  • NRIX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than NRIX.

Price Growth

CGEM (@Biotechnology) experienced а +31.41% price change this week, while NRIX (@Biotechnology) price change was -6.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

CGEM is expected to report earnings on Nov 06, 2025.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($705M) has a higher market cap than CGEM($457M). CGEM YTD gains are higher at: -36.453 vs. NRIX (-51.274). CGEM has higher annual earnings (EBITDA): -234.39M vs. NRIX (-248.7M). NRIX has more cash in the bank: 429M vs. CGEM (265M). CGEM has less debt than NRIX: CGEM (1.52M) vs NRIX (56.5M). NRIX has higher revenues than CGEM: NRIX (83.7M) vs CGEM (0).
CGEMNRIXCGEM / NRIX
Capitalization457M705M65%
EBITDA-234.39M-248.7M94%
Gain YTD-36.453-51.27471%
P/E RatioN/AN/A-
Revenue083.7M-
Total Cash265M429M62%
Total Debt1.52M56.5M3%
TECHNICAL ANALYSIS
Technical Analysis
CGEMNRIX
RSI
ODDS (%)
Bullish Trend 8 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 8 days ago
74%
Bearish Trend 8 days ago
90%
Momentum
ODDS (%)
Bullish Trend 8 days ago
72%
Bullish Trend 8 days ago
80%
MACD
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 8 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
73%
Bullish Trend 8 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
73%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 20 days ago
89%
Bearish Trend 23 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 8 days ago
88%
Aroon
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RESGX16.810.11
+0.66%
Glenmede Environmental Accountability
TIIRX29.24N/A
N/A
Nuveen Core Equity A
PURYX61.17-0.02
-0.03%
Putnam U.S. Research Y
BRXIX16.70-0.06
-0.36%
MFS Blended Research Intl Eq I
WIIGX23.45-0.13
-0.55%
Wasatch International Growth Instl

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with IDYA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-1.15%
IDYA - CGEM
53%
Loosely correlated
+1.12%
VRDN - CGEM
48%
Loosely correlated
-2.76%
BDTX - CGEM
48%
Loosely correlated
-1.05%
DNLI - CGEM
48%
Loosely correlated
+1.54%
NRIX - CGEM
47%
Loosely correlated
-5.56%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-5.56%
KYMR - NRIX
66%
Closely correlated
-2.72%
DNLI - NRIX
58%
Loosely correlated
+1.54%
IDYA - NRIX
58%
Loosely correlated
+1.12%
NUVL - NRIX
55%
Loosely correlated
-5.67%
SYRE - NRIX
55%
Loosely correlated
+11.02%
More